The Competition Commission of India (CCI) in an order dated 13
August 2021 declined to initiate investigation into allegations of
abuse of dominant position and anticompetitive vertical agreements
against Siemens Healthcare Private Limited (Siemens).
Background:
An information (complaint) was filed by Star Imaging and Path
Lab Private Limited and Janta X-Ray Clinic Private Limited
(collectively, "Informants"), companies involved in
providing diagnostics and pathology lab services in Delhi.
The Informants alleged abuse of dominant position and
anti-competitive vertical agreements by Siemens Ltd., Siemens
Aktiengesellschaft and Siemens (collectively, "Siemens
Group") in contravention of Section 3 (4) and Section 4 of the
Competition Act, 2002 (Act). Pertinently, allegations were made
against Siemens Ltd. and Siemens Aktiengesellschaft, despite the
fact that they have not been engaged in the healthcare business in
India since mid-2015.
